Literature DB >> 28134505

China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version).

Yuankai Shi1, Yan Sun1, Jinming Yu2, Cuimin Ding3, Ziping Wang4, Changli Wang5, Dong Wang6, Cunde Wang7, Zheng Wang8, Mengzhao Wang9, Xiuyi Zhi10, You Lu11, Jifeng Feng12, Yunpeng Liu13, Xiaoqing Liu14, Wei Liu4, Gang Wu15, Xiaomei Li16, Kai Li5, Enxiao Li17, Wei Li18, Gongyan Chen19, Zhengtang Chen20, Ping Yu21, Ning Wu22, Milu Wu23, Wenhua Xiao24, Li Zhang9, Yiping Zhang25, Shucai Zhang26, Shujun Yang27, Xia Song28, Dongmei Lin4, Rongcheng Luo29, Li Shan30, Caicun Zhou31, Zongmei Zhou22, Qiong Zhao32, Chengping Hu33, Yi Hu16, Qisen Guo2, Jianhua Chang34, Cheng Huang35, Xuan Zeng9, Baohui Han36, Xiaohong Han1, Bo Jia1, Ying Han1, Yu Huang1.   

Abstract

Entities:  

Year:  2016        PMID： 28134505     DOI： 10.1111/ajco.12608

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN： 1743-7555            Impact factor:   2.601


× No keyword cloud information.
  17 in total

1.  Synergistic inhibitory effect of berberine and icotinib on non-small cell lung cancer cells via inducing autophagic cell death and apoptosis.

Authors:  Ping Chen; Chun-Hua Dai; Zhi-Hao Shi; Yi Wang; Jian-Nong Wu; Kang Chen; Jin-Yu Su; Jian Li
Journal:  Apoptosis       Date:  2021-11-07       Impact factor: 4.677

2.  Associations of MTA1 expression with CT features, pathology and prognosis of elderly patients with non-small cell lung cancer.

Authors:  Ning Yang; Chuanming Li; Xiao Han; Zhihua Feng; Feng Qiu; Junqing Han
Journal:  Oncol Lett       Date:  2020-08-28       Impact factor: 2.967

3.  Influence and mechanism of lung cavitation development on antiangiogenic therapy.

Authors:  Man Jiang; Chuantao Zhang; Dong Liu; Yongjie Wang; Hongmei Wang; Tianjun Li; Helei Hou; Na Zhou; Jingjuan Zhu; Hongying Lv; Chuanyu Zhang; Bingliang Fang; Xiaochun Zhang
Journal:  Transl Lung Cancer Res       Date:  2019-08

4.  A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.

Authors:  Chih-Yang Huang; Da-Tong Ju; Chih-Fen Chang; P Muralidhar Reddy; Bharath Kumar Velmurugan
Journal:  Biomedicine (Taipei)       Date:  2017-11-13

5.  Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway.

Authors:  Yong-An Song; Ting Ma; Xue-Yan Zhang; Xiang-Song Cheng; Ayobami-Matthew Olajuyin; Zhi-Fu Sun; Xiao-Ju Zhang
Journal:  Cancer Cell Int       Date:  2019-05-02       Impact factor: 5.722

6.  EGFR T790M detection in formalin-fixed paraffin-embedded tissues of patients with lung cancer using RNA-based in situ hybridization: A preliminary feasibility study.

Authors:  Shafei Wu; Xiaohua Shi; Xiaoyan Si; Yuanyuan Liu; Tao Lu; Li Zhang; Zhiyong Liang; Xuan Zeng
Journal:  Thorac Cancer       Date:  2019-08-13       Impact factor: 3.500

7.  Antiangiogenic effects of recombinant human endostatin in lung cancers.

Authors:  Lang He; Chaofen Zhao; Yunxiang Li; Guocheng Du; Kang Liu; Dandan Cui; Lina Tang; Xun Wu; Shimin Wen; Hong Chen
Journal:  Mol Med Rep       Date:  2017-10-24       Impact factor: 2.952

Review 8.  Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis.

Authors:  Yuqiao Chen; Xiong Peng; Yuan Zhou; Kun Xia; Wei Zhuang
Journal:  World J Surg Oncol       Date:  2018-01-16       Impact factor: 2.754

9.  Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study.

Authors:  Jianping Xu; Xiaoyan Liu; Sheng Yang; Xiangru Zhang; Yuankai Shi
Journal:  Onco Targets Ther       Date:  2017-10-13       Impact factor: 4.147

10.  Achievable complete remission of advanced non-small-cell lung cancer: Case report and review of the literature.

Authors:  Ning-Ning Yang; Fei Xiong; Qing He; Yong-Song Guan
Journal:  World J Clin Cases       Date:  2018-07-16       Impact factor: 1.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.